Cited by 293Barrier Structure and Function StudiesAlzheimer's disease research and treatmentsIntracerebral and Subarachnoid Hemorrhage Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Carrano, Anna, Hoozemans, Jeroen J.M., van der Vies, Saskia M., Rozemuller, Annemieke J.M., van Horssen, Jack, de Vries, Helga E.·2011·Antioxidants & Redox Signaling

DOI 10.1089/ars.2011.3895

Open this paper in CoChat — free account

Abstract

Cerebral amyloid angiopathy (CAA) is frequently observed in Alzheimer's disease (AD) and is characterized by deposition of amyloid beta (Aβ) in leptomeningeal and cortical brain vasculature. In 40% of AD cases, Aβ mainly accumulates in cortical capillaries, a phenomenon referred to as capillary CAA (capCAA). The aim of this study was to investigate blood-brain barrier (BBB) alterations in CAA-affected capillaries with the emphasis on tight junction (TJ) changes. First, capCAA brain tissue was analyzed for the distribution of TJs. Here, we show for the first time a dramatic loss of occludin, claudin-5, and ZO-1 in Aβ-laden capillaries surrounded by NADPH oxidase-2 (NOX-2)-positive activated microglia. Importantly, we observed abundant vascular expression of the Aβ transporter receptor for advanced glycation endproducts (RAGE). To unravel the underlying mechanism, a human brain endothelial cell line was stimulated with Aβ1-42 to analyze the effects of Aβ. We observed a dose-dependent cytotoxicity and increased ROS generation, which interestingly was reversed by administration of exogenous antioxidants, NOX-2 inhibitors, and by blocking RAGE. Taken together, our data evidently show that Aβ is toxic to brain endothelial cells via binding to RAGE and induction of ROS production, which ultimately leads to disruption of TJs and loss of BBB integrity.

Integrity signals

Registry

Crossref · 10.1089/ars.2011.3895

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Staging of AD was evaluated according to Braak and colleagues (7).”
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E.-A., Perrière, N., Charneau, P., Holloway, K. E., Leveque, M., Tricoire-Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,325
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,088
An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease
Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531
RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487

Flagged first, then by citations

Show all 50 references

Research works printed but not linked: 5

10.1080/15216540051080976 · DOI
Higuchi Y, 1987, Jpn J Psychiatry Neurol, 41, 283
Kalaria RN, 1992, Cerebrovasc Brain Metab Rev, 4, 226
Tai LM, 2010, J Cell Mol Med, 14, 1101
Yamashita K, 1991, Jpn J Psychiatry Neurol, 45, 79

Sorted by citations

Items 101–200 of 293

Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease
Berk, C., & Sabbagh, M. N. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0108-6 · Cited by 63
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction
Bandyopadhyay, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653334 · Cited by 64
Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity
Song, J., Choi, S., Whitcomb, D. J., & Kim, B. C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.491 · Cited by 62
Ajmalicine and Reserpine: Indole Alkaloids as Multi-Target Directed Ligands Towards Factors Implicated in Alzheimer’s Disease
Kashyap, P., Kalaiselvan, V., Kumar, R. S., & Kumar, S. (2020) · Molecules · doi:10.3390/molecules25071609 · Cited by 59
Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood–brain barrier model
Qosa, H., LeVine, H., Keller, J. N., & Kaddoumi, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.029 · Cited by 64
The Interplay Between Beta-Amyloid 1–42 (Aβ1–42)-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits
Guzmán, B. C., Chaffey, T. E., Palpagama, T. H., Waters, S., Boix, J., Tate, W. P., Peppercorn, K., Dragunow, M., Waldvogel, H. J., Faull, R. L. M., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.552073 · Cited by 63
Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction
Gireud, M., Mack, A. F., McCullough, L. D., & Urayama, A. (2020) · The Neuroscientist · doi:10.1177/1073858420954811 · Cited by 66
A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58
Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults
Agrawal, S., & Schneider, J. A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100148 · Cited by 61
Mechanisms Underlying Brain Aging Under Normal and Pathological Conditions
Jin, M., & Cai, S. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00969-9 · Cited by 61
Don't forget astrocytes when targeting Alzheimer's disease
Sadick, J. S., & Liddelow, S. A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14568 · Cited by 60
Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium
d’Uscio, L. V., He, T., & Katušić, Z. S. (2016) · Physiology · doi:10.1152/physiol.00021.2016 · Cited by 57
Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro
Cuevas, E., Rosas-Hernández, H., Burks, S. M., Ramirez-Lee, M. A., Guzmán, A., Imam, S. Z., Ali, S. F., & Sarkar, S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00447-8 · Cited by 58
EGb761 Provides a Protective Effect against Aβ1-42 Oligomer-Induced Cell Damage and Blood-Brain Barrier Disruption in an In Vitro bEnd.3 Endothelial Model
Wan, W., Cao, L., Liu, L., Kalionis, B., Chen, C., Tai, X., Li, Y., & Xia, S.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113126 · Cited by 55
Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments
Parfenov, V. A., Ostroumova, O. D., Оstroumova, Т. М., Кочетков, А. И., Fateeva, V. V., Khacheva, K. K., Khakimova, G. R., & Epstein, O. I. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s197032 · Cited by 56
Impact of intestinal disorders on central and peripheral nervous system diseases
El-Hakim, Y., Bake, S., Mani, K. K., & Sohrabji, F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105627 · Cited by 54
Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate
Pizcueta, P. M., Vergara, C., Emanuele, M., Vilalta, A., Rodríguez‐Pascau, L., & Martinell, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043201 · Cited by 55
Retinal arterial Aβ40 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients
Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Jallow, O., Mandalia, K., Graham, S. L., Gupta, V., Mirzaei, M., Kramerov, A. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13086 · Cited by 52
Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride
Giunta, S., Andriolo, V., & Castorina, A. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.07.009 · Cited by 54
MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1
Liu, W., Cai, H., Lin, M., Zhu, L., Gao, L., Zhong, R., Bi, S., Xue, Y., & Shang, X. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.026 · Cited by 57
Aβ1–42 oligomer induces alteration of tight junction scaffold proteins via RAGE-mediated autophagy in bEnd.3 cells
Chan, Y., Chen, W., Wan, W., Chen, Y., Li, Y., & Zhang, C. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.05.025 · Cited by 55
In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies
Palmiotti, C. A., Prasad, S., Naik, P. U., Kaisar, M. A., Sajja, R. K., Achyuta, A. H., & Cucullo, L. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1464-6 · Cited by 56
Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit
Veszelka, S., Tóth, A. E., Walter, F. R., Datki, Z., Mózes, E., Fülöp, L., Bozsó, Z., Hellinger, É., Vastag, M., Orsolits, B., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-120163 · Cited by 55
ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy
Carrano, A., Snkhchyan, H., Kooij, G., van der Pol, S., van Horssen, J., Veerhuis, R., Hoozemans, J., Rozemuller, A., & de Vries, H. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.015 · Cited by 51
Self-citation
FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness
Canepa, E., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Gamallo‐Lana, B., Guzman‐Hernandez, R. A., Lemon, N. L., Angiulli, F., Debure, L., Ilies, M. A., Østergaard, L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13063 · Cited by 54
T Cells—Protective or Pathogenic in Alzheimer’s Disease?
McManus, R. M., Mills, K. H. G., & Lynch, M. A. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9612-2 · Cited by 54
Endothelial dysfunctions in blood-brain barrier breakdown in alzheimer's disease: from mechanisms to potential therapies
Yue, Q., Leng, X., Xie, N., Zhang, Z., Yang, D., & Hoi, M. P. M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70079 · Cited by 48
Viola tricolorInduces Apoptosis in Cancer Cells and Exhibits Antiangiogenic Activity on Chicken Chorioallantoic Membrane
Sadeghnia, H. R., Hesari, T. G., Mortazavian, S. M., Mousavi, S. H., Tayarani‐Najaran, Z., & Ghorbani, A. (2014) · BioMed Research International · doi:10.1155/2014/625792 · Cited by 48
Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative Stress
Yokokawa, K., Iwahara, N., Hisahara, S., Emoto, M. C., Saito, T., Suzuki, H., Manabe, T., Matsumura, A., Matsushita, T., Suzuki, S., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190817 · Cited by 48
Amyloid-β Interacts with Blood-Brain Barrier Function in Dementia: A Systematic Review
Burgmans, S., van de Haar, H. J., Verhey, F. R. J., & Backes, W. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122155 · Cited by 48
Angiopoietin like-4 as a novel vascular mediator in capillary cerebral amyloid angiopathy
Chakraborty, A., Kamermans, A., van het Hof, B., Castricum, K., Aanhane, E., van Horssen, J., Thijssen, V. L., Scheltens, P., Teunissen, C. E., Fontijn, R. D., et al. (2018) · Brain · doi:10.1093/brain/awy274 · Cited by 45
Aging Neurovascular Unit and Potential Role of DNA Damage and Repair in Combating Vascular and Neurodegenerative Disorders
Li, Y., Xie, L., Huang, T., Zhang, Y., Zhou, J., Qi, B., Wang, X., Chen, Z., & Li, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00778 · Cited by 47
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease
Zeng, J., Liao, Z., Yang, H., Wang, Q., Wu, Z., Hua, F., & Zhou, Z. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106461 · Cited by 53
Alzheimer's disease pathology is associated with earlier alterations to blood–brain barrier water permeability compared with healthy ageing in TgF344‐AD rats
Dickie, B., Boutin, H., Parker, G. J. M., & Parkes, L. M. (2021) · NMR in Biomedicine · doi:10.1002/nbm.4510 · Cited by 45
Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Custodia, A., Aramburu-Núñez, M., Rodríguez‐Arrizabalaga, M., Peleteiro, J. M. P., Vázquez‐Vázquez, L., Camino-Castiñeiras, J., Aldrey, J. M., Castillo, J., Ouro, A., Sobrino, T., et al. (2023) · Cells · doi:10.3390/cells12060962 · Cited by 47
Endothelial leakiness elicited by amyloid protein aggregation
Li, Y., Ni, N., Lee, M., Wei, W., Andrikopoulos, N., Käkinen, A., Davis, T. P., Song, Y., Ding, F., Leong, D. T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44814-1 · Cited by 52
Chronic Cerebral Hypoperfusion Activates the Coagulation and Complement Cascades in Alzheimer's Disease Mice
Shi, X., Ohta, Y., Liu, X., Shang, J., Morihara, R., Nakano, Y., Feng, T., Huang, Y. C., Sato, K., Takemoto, M., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.050 · Cited by 45
Pinocembrin Protects Human Brain Microvascular Endothelial Cells against Fibrillar Amyloid-β1−40Injury by Suppressing the MAPK/NF-κB Inflammatory Pathways
Liu, R., Li, J.-Z., Song, J.-K., Sun, J., Li, Y., Zhou, S., Zhang, T., & Du, G. (2014) · BioMed Research International · doi:10.1155/2014/470393 · Cited by 43
Implication of type 4 NADPH oxidase (NOX4) in tauopathy
Luengo, E., Trigo-Alonso, P., Fernández‐Mendívil, C., Núñez, Á., del Campo, M., Porrero, C., García‐Magro, N., Negredo, P., Senar, S., Sánchez‐Ramos, C., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.redox.2021.102210 · Cited by 44
Self-citation
Altered blood–brain barrier transport in neuro-inflammatory disorders
Schenk, G. J., & de Vries, H. E. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.002 · Cited by 44
Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42
Yu, G., Liu, C., Bai, K., Liu, X., & Li-mi, Z. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239445 · Cited by 42
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis
Lemche, E., Killick, R., Mitchell, J., Caton, P., Choudhary, P., & Howard, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106485 · Cited by 45
Pathobiology of Junctional Adhesion Molecules
Bazzoni, G. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3867 · Cited by 41
Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathology
Gustafsson, S. S., Lindström, V., Ingelsson, M., Hammarlund‐Udenaes, M., & Syvänen, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.002 · Cited by 39
Ion channel remodeling in gastrointestinal inflammation
Akbarali, H. I., Hawkins, E. G., Ross, G. R., & Kang, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01560.x · Cited by 41
Cerebral amyloid angiopathy impact on endothelium
Grinberg, L. T., Korczyn, A. D., & Heinsen, H. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.005 · Cited by 42
Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy
Cheng, X., He, P., Yao, H., Dong, Q., Li, R., & Shen, Y. (2014) · Neurology · doi:10.1212/wnl.0000000000000403 · Cited by 39
Fibronectin induces the perivascular deposition of cerebrospinal fluid–derived amyloid-β in aging and after stroke
Howe, M. D., Atadja, L. A., Furr, J. W., Maniskas, M. E., Zhu, L., McCullough, L. D., & Urayama, A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.019 · Cited by 36
Modulating the paracellular pathway at the blood–brain barrier: current and future approaches for drug delivery to the CNS
O’Keeffe, E., & Campbell, M. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.008 · Cited by 37
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40
Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs
Akhtar, A., Singh, S., Kaushik, R., Awasthi, R., & Behl, T. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102289 · Cited by 38
TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer’s microenvironment
Liu, Q., Zhu, L., Liu, X., Zheng, J., Liu, Y., Ruan, X., Cao, S., Cai, H., Li, Z., & Xue, Y. (2020) · RNA Biology · doi:10.1080/15476286.2020.1756055 · Cited by 33
The Blood-Brain Barrier in Alzheimer’s Disease
Storck, S. E., Hartz, A. M. S., & Pietrzik, C. U. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_418 · Cited by 31
Use of Zebrafish Genetic Models to Study Etiology of the Amyloid-Beta and Neurofibrillary Tangle Pathways in Alzheimer's Disease
Freeman, J. L., & Kiper, K. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210524155944 · Cited by 33
Unravelling the glial response in the pathogenesis of Alzheimer's disease
Alibhai, J. D., Diack, A. B., & Manson, J. C. (2018) · The FASEB Journal · doi:10.1096/fj.201801360r · Cited by 31
SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer’s Disease
Unzeta, M., Hernández‐Guillamón, M., Sun, P., & Solé, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073365 · Cited by 34
NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases
Sindona, C., Schepici, G., Contestabile, V., Bramanti, P., & Mazzon, E. (2021) · Medicina · doi:10.3390/medicina57060604 · Cited by 35
Pathogeneses and Imaging Features of Cerebral White Matter Lesions of Vascular Origins
Wu, X., Ya, J., Zhou, D., Ding, Y., Ji, X., & Meng, R. (2021) · Aging and Disease · doi:10.14336/ad.2021.0414 · Cited by 32
Claudin-5 relieves cognitive decline in Alzheimer’s disease mice through suppression of inhibitory GABAergic neurotransmission
Zhu, N., Wei, M., Yuan, L., He, X., Chen, C., Ji, A., & Zhang, G. (2022) · Aging · doi:10.18632/aging.204029 · Cited by 34
Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier
Griffin, J. M., Kho, D. T., Graham, E. S., Nicholson, L. F. B., & O’Carroll, S. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157483 · Cited by 32
The Methylglyoxal/RAGE/NOX-2 Pathway is Persistently Activated in the Hippocampus of Rats with STZ-Induced Sporadic Alzheimer’s Disease
Moreira, A. P., Vizuete, A. F. K., Zin, L. E. F., Marques, C. D. O., Pacheco, R. F., Leal, M. B., & Gonçalves, C. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00476-9 · Cited by 30
Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
Tao, Q., Lin, R.-R., Chen, Y.-H., & Wu, Z. (2022) · Aging and Disease · doi:10.14336/ad.2022.0130-1 · Cited by 34
Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy
de Wit, N. M., Snkhchyan, H., den Hoedt, S., Wattimena, D. J. L., de Vos, R., Mulder, M. T., Walter, J., Martínez‐Martínez, P., Hoozemans, J. J. M., Rozemüller, A. J. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160551 · Cited by 31
Self-citation
Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer’s Disease
Rosas-Hernández, H., Cuevas, E., Raymick, J. B., Robinson, B. L., & Sarkar, S. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.024 · Cited by 30
Alzheimer’s disease: The role of T lymphocytes in neuroinflammation and neurodegeneration
Asamu, M. O., Oladipo, O. O., Abayomi, O. A., & Adebayo, A. A. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148589 · Cited by 32
La barrière hémato-encéphalique
Gosselet, F., Candela, P., Cecchelli, R., & Fénart, L. (2011) · médecine/sciences · doi:10.1051/medsci/20112711015 · Cited by 42
Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy
Kelly, L., Brown, C., Michalik, D., Hawkes, C. A., Aldea, R., Agarwal, N., Salib, R. J., Alzetani, A., Ethell, D. W., Counts, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13512 · Cited by 31
The role of platelets in the blood-brain barrier during brain pathology
Lv, W., Jiang, X., & Zhang, Y. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1298314 · Cited by 30
Amyloid- β disrupts unitary calcium entry through endothelial NMDA receptors in mouse cerebral arteries
Peters, E. C., Gee, M. T., Pawlowski, L. N., Kath, A. M., Polk, F. D., Vance, C. J., Sacoman, J. L., & Pires, P. W. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211039592 · Cited by 31
Tight Junctions and Tissue Barriers
Blasig, I. E., & Haseloff, R. F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4003 · Cited by 28
Brown rats on farmland
Macdonald, D. W., Berdoy, M., & Webster, J. P. (2015) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198745501.003.0011 · Cited by 27
A Fundamental Role for Oxidants and Intracellular Calcium Signals in Alzheimer’s Pathogenesis—And How a Comprehensive Antioxidant Strategy May Aid Prevention of This Disorder
McCarty, M. F., DiNicolantonio, J. J., & Lerner, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042140 · Cited by 27
Murine Beta-Amyloid (1–42) Oligomers Disrupt Endothelial Barrier Integrity and VEGFR Signaling via Activating Astrocytes to Release Deleterious Soluble Factors
Yue, Q., Zhou, X., Zhang, Z., & Hoi, M. P. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031878 · Cited by 26
Telomerase reverse transcriptase and neurodegenerative diseases
Yu, X., Liu, M., Zheng, C., Liu, Y., Wang, Z., & Wang, Z.-Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1165632 · Cited by 25
RAGE induces physiological activation of NADPH oxidase in neurons and astrocytes and neuroprotection
Seryogina, E. S., Kamynina, A. V., Koroev, D. O., Volpina, O. M., Vinokurov, A. Y., & Abramov, A. Y. (2024) · FEBS Journal · doi:10.1111/febs.17086 · Cited by 25
Inflammation at the blood-brain barrier: The role of liver X receptors
de Wit, N. M., Vanmol, J., Kamermans, A., Hendriks, J. J. A., & de Vries, H. E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.015 · Cited by 27
Inflammation, Nitro-Oxidative Stress, Impaired Autophagy, and Insulin Resistance as a Mechanistic Convergence Between Arterial Stiffness and Alzheimer’s Disease
Hendrickx, J. O., Martinet, W., Dam, D. V., & Meyer, G. R. Y. D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.651215 · Cited by 28
Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer’s Disease—Are Systemic Approaches for Diagnosis and Therapy Required?
Förster, C. Y., Shityakov, S., Scheper, V., & Lenarz, T. (2022) · Biomolecules · doi:10.3390/biom12111717 · Cited by 30
Impact of Age on the Cerebrovascular Proteomes of Wild-Type and Tg-SwDI Mice
Searcy, J. L., Bihan, T. L., Salvadores, N., McCulloch, J., & Horsburgh, K. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089970 · Cited by 24
Overlapping Protein Accumulation Profiles of CADASIL and CAA
Young, K. Z., Xu, G., Keep, S. G., Borjigin, J., & Wang, M. M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.11.015 · Cited by 24
Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment
Leitner, D., Kavanagh, T., Kanshin, E., Balcomb, K., Pires, G., Thierry, M., Suazo, J. I., Schneider, J. A., Ueberheide, B. M., Drummond, E., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02767-1 · Cited by 30
Photobiomodulation for Hypertension and Alzheimer’s Disease
Valverde, A., & Mitrofanis, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220632 · Cited by 22
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
Ritson, M., Wheeler-Jones, C. P. D., & Stolp, H. B. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578363 · Cited by 23
Transcriptomic Profile of Blood–Brain Barrier Remodeling in Cerebral Amyloid Angiopathy
Situ, M., Citalán‐Madrid, A. F., Stamatovic, S. M., Keep, R. F., & Andjelkovic, A. V. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.931247 · Cited by 21
Vascular endothelial cells: a fundamental approach for brain waste clearance
Wei, H., Jiang, H., Zhou, Y., Xiao, X., Zhou, C., & Ji, X. (2022) · Brain · doi:10.1093/brain/awac495 · Cited by 20
Analysis of Cerebral Small Vessel Changes in AD Model Mice
Shibly, A. Z., Sheikh, A. M., Michikawa, M., Tabassum, S., Azad, A. K., Zhou, X., Zhang, Y., Yano, S., & Nagai, A. (2022) · Biomedicines · doi:10.3390/biomedicines11010050 · Cited by 21
Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator
Xia, X., Wei, Y., Huang, Q., Zhou, Y., Wang, X., Shi, Y., Yang, X., Yang, W., Zhang, Y., Lei, T., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.017 · Cited by 20
Neuroprotective Effect of Halophyte Salicornia herbacea L. Is Mediated by Activation of Heme Oxygenase-1 in Mouse Hippocampal HT22 Cells
Kim, M. S., Seo, J. Y., Oh, J., Jang, Y. K., Lee, C. H., & Kim, J. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3829 · Cited by 20
Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice
Park, S. M., Shin, J. H., Moon, G. J., Cho, S. I., Lee, Y. B., & Gwag, B. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-106 · Cited by 19
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer’s Disease
Su, M., Nizamutdinov, D., Liu, H., & Huang, J. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119272 · Cited by 26
Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer’s disease
Pallebage‐Gamarallage, M. M., Takechi, R., Lam, V., Elahy, M., & Mamo, J. C. L. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1115820 · Cited by 20
Harnessing the immune system for the treatment of Parkinson’s disease
Vedam‐Mai, V. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147308 · Cited by 20
The Breakdown of Neurovascular Barriers: Molecular Mechanisms of Tight Junction Dysfunction
Gopal, S. S., Kaur, M., Lanzkron, S., & Srivastava, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05592-z · Cited by 20
Effects of Kaixinjieyu, a Chinese herbal medicine preparation, on neurovascular unit dysfunction in rats with vascular depression
Pan, J., Lei, X., Wang, J., Huang, S., Wang, Y., Zhang, Y., Chen, W., Li, D., Zheng, J., Cui, H., et al. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0808-z · Cited by 18
Acetylcholinesterase Inhibitors Promote Angiogenesis in Chick Chorioallantoic Membrane and Inhibit Apoptosis of Endothelial Cells
Mortazavian, S. M., Parsaee, H., Mousavi, S. H., Tayarani‐Najaran, Z., Ghorbani, A., & Sadeghnia, H. R. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/121068 · Cited by 19
Effect of catechins and high-temperature-processed green tea extract on scavenging reactive oxygen species and preventing Aβ1–42fibrils’ formation in brain microvascular endothelium
Lee, S.-B., Choi, E., Jeong, K.-H., Kim, K.-S., Shim, S., & Kim, G.-H. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1507618 · Cited by 19
The Conspicuous Link between Ear, Brain and Heart–Could Neurotrophin-Treatment of Age-Related Hearing Loss Help Prevent Alzheimer’s Disease and Associated Amyloid Cardiomyopathy?
Shityakov, S., Hayashi, K., Störk, S., Scheper, V., Lenarz, T., & Förster, C. Y. (2021) · Biomolecules · doi:10.3390/biom11060900 · Cited by 18
NOX2 in Alzheimer's and Parkinson's disease
Dustin, C. M., Shiva, S. S., Vazquez, A. L., Saeed, A., Pascoal, T. A., Cifuentes-Pagano, E., & Pagano, P. J. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103433 · Cited by 19
Autophagy in alzheimer disease pathogenesis and its therapeutic values
Angst, G., Jia, N., Esqueda, L. T., Fan, Y., Cai, Q., & Wang, C. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2471677 · Cited by 22
Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer’s Disease
Lai, G., Wu, H., Yang, K., Hu, K., Zhao, W., Chen, X., Li, J., Haifeng, W., Lv, Z., Xie, G., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s525960 · Cited by 19

Authors: Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., Rozemuller, A. J. M., van Horssen, J., & de Vries, H. E.
Affiliations: Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Departments of Molecular Cell Biology and Immunology (MCBI) and Pathology, VU University Medical Center, Amsterdam, The Netherlands.
ORCID: Carrano, Anna
Hoozemans, Jeroen J.M.
Venue: Antioxidants & Redox Signaling
Publisher: SAGE Publications
Published: 2011-09
Volume: 15
Issue: 5
Pages: 1167-1178
ISSN: 1523-0864 (ISSN-L)
1557-7716
DOI: 10.1089/ars.2011.3895
OpenAlex: W2054446458
Cited by: 293
References: 50
Citations by year: 2026: 11 · 2025: 16 · 2024: 30 · 2023: 21 · 2022: 34 · 2021: 27 · 2020: 21 · 2019: 13 · 2018: 17 · 2017: 11 · 2016: 18 · 2015: 20 · 2014: 14 · 2013: 16 · 2012: 10
FWCI: 9.19
Type: journal article
Language: en
Open access: closed
Locations: Antioxidants and Redox Signaling (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
VU Research Portal (publishedVersion)
Pure Amsterdam UMC (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Chinese Academy of Agricultural Sciences
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords: cerebral amyloid angiopathy, amyloid-beta, blood-brain barrier, tight junctions, oxidative stress, reactive oxygen species, NADPH oxidase 2, microglia, receptor for advanced glycation end products, RAGE, brain endothelial cells, occludin, claudin-5, ZO-1, Alzheimer's disease, antioxidant defense
MeSH terms: Receptor for Advanced Glycation End Products, NADPH Oxidase 2, Aged, Aged, 80 and over, Antioxidants, Blood-Brain Barrier, Capillaries, Cell Line, Female, Gene Expression Regulation, Humans, Male, Membrane Glycoproteins, Membrane Proteins, Phosphoproteins, RNA, Messenger, Down-Regulation, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Reactive Oxygen Species, Microglia, Oxidative Stress, Tight Junctions, NADPH Oxidases, Endothelial Cells, Occludin, Zonula Occludens-1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks